2024 ADLM|BIOELAB Comes to Global Inspection Event, the 2024 ADLM|BIOELAB Comes to Global Inspection Event, the

2024 ADLM|BIOELAB Comes to Global Inspection Event, the "Light of Innovation" Continues to Shine!

2024-08-01 Hits:243

From July 30th to August 1st in the United States, the 76th Association for Diagnostics & Laboratory Medicine (ADLM) was grandly opened at the McCormick Exhibition Center in Chicago. Nanjing BIOELAB showcased multiple series of in vitro diagnostic intelligent products and communicated with attending experts, allowing the "light of innovation" to shine on the world stage!



ADLM, which takes place annually in different cities in the United States in July, is the highest quality and largest annual event in the field of clinical testing among the world. This exhibition has tremendous international influence, attracting over 20000 international medical professionals from 110 countries every year. ADLM has become an important platform for the release of new products, seeking cooperation, and communication in the field of clinical laboratory testing worldwide.



After a year, BIOELAB is poised to move forward and innovate. Multiple series of IVD new products concerning chemistry, luminescent, hematology and coagulation analyzers and so on had crossed the ocean and made a stunning appearance at booth 245 of BIOELAB, welcoming the visit and exchange of global experts and customers.



At the exhibition, our company's salesmen, with their pioneering spirit of exploration and sharing, took this opportunity to explore new technologies, business opportunities, and formats in the field of in vitro diagnostics with overseas customers. Not only did this experience broaden their horizons, but also it brought new opportunities for future development.



Solving disadvantages is the key to showcasing advantages. In recent years, as a professional manufacturer integrating research and development, design, production, and sales of IVD products in China, BIOELAB has not only focused on the domestic market but also on the global market, meticulously cultivating the international market and continuously providing high-quality products and advanced automation solutions for in vitro diagnostics.


Independently innovating and chasing for quality first, our company's newly developed multiple products this year are eye-catching, embodying the original intention of BIOELAB to serve global healthcare.


Hematology analyzer is an essential instrument for medical testing, which can be used for various blood related disease detection, monitoring, prognosis, and subsequent screening. From three-parts to five-parts, the series of our products has gradually matured.


The auto five-parts hematology analyzer EC-51 has a speed of 60 T/H and uses 15 μL of blood. The analyzer, which focuses on detecting trace amounts of blood, is precise and reliable, simplifies complexity and can easily remove obstacles with just one click, ensuring worry free operation throughout the whole year.


The auto three-parts hematology analyzer EC-38 has the characteristics of high accuracy and low reagent consumption, making it the preferred choice for emergency treatment. The instrument is exquisite, compact, easy to operate, and has low maintenance costs, suitable for various scenarios, providing more solutions for in vitro diagnostics.



The auto chemistry analyzer BT-330 uses dual reagents for 330 T/H, with a constant and stable rate. This kind of analyzer, which is fast and efficient, is a good choice because of its strengths in liquid level detection, continuous tracking, vertical collision prevention and needle blockage detection.



The first auto chemiluminescence immunoassay analyzer IA-200 can reach the fastest analysis speed of 200T/H and the first report time is 14 minutes. The reagents can be replaced online and the samples can be loaded without interruption. With multiple magnetic separation cleaning, efficient B/F separation and compact desktop design which can be placed anywhere, this kind of analyzer can meet various testing needs.



The automatic coagulation analyzer CL-600 adopts advanced and innovative light source dynamic enhancement technology. The instrument can select the optimal detection wavelength according to the sample state, with intelligent anti-interference and high sensitivity. The instrument adopts a pull-out bracket design, and all materials support non-stop online loading, saving time and effort.



The end of each ADLM represents the beginning of a new round of efforts for BIOELAB. More than ten years of innovation and accumulation have created excellent situation now. The future is coming, and BIOELAB team, with a long way to go, will continue to strive for excellence and bring more intelligent and professional IVD products and higher quality service to the global market.


In 2024, looking forward to being with you in any places of the world, goodbye!